Factor | Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% confidence interval | p-value | Hazard ratio | 95% confidence interval | P-value | |
CCI | 1.2 | (0.97–1.5) | 0.09 | 1.33 | (1.02–1.73) | 0.037 |
MELD-Na | 1.22 | (1.16–1.29) | < 0.001 | 1.26 | (1.18–1.33) | < 0.001 |
Age | 1.01 | (0.98–1.06) | 0.5 | 1.02 | (0.96–1.07) | 0.5 |
Male gender | 2.4 | (1.03–5.4) | 0.043 | 1.2 | (0.5–3) | 0.6 |
Body mass index | 1.01 | (0.96–1.07) | 0.4 | 1.02 | (0.96–1.09) | 0.4 |
Race (reference white) | ||||||
Black | 2.2 | (0.7–7.1) | 0.2 | 2.9 | (0.8–11) | 0.12 |
Hispanic | 1.9 | (0.5–7.9) | 0.4 | 0.4 | (0.1–1.7) | 0.19 |
Asian | NAa | NAa | ||||
Etiology liver disease (Reference alcohol) | ||||||
Alcohol and viral | 2.4 | (0.7–8) | 0.15 | 2.8 | (0.8–9.8) | 0.08 |
Viral | 1.9 | (0.6–6) | 0.24 | 2.3 | (0.7–7.8) | 0.15 |
Autoimmune | NAa | NAa | ||||
Fatty liver | 1.6 | (0.5–5.5) | 0.4 | 3.3 | (0.8–14.3) | 0.11 |
Cryptogenic | 2.1 | (0.2–18.8) | 0.5 | 2.6 | (0.2–31) | 0.5 |
Hepatocellular carcinoma | 1.4 | (0.7–2.9) | 0.4 | 2 | (0.8–5) | 0.11 |